still which progress for reported we late equity made came January than first HOLO recent our revenue Portal discussed of the guidance less in We’ve which first million, investment a annual our quarter, our as clearance Inteneural momentum $XX.X we year was most surgical our quarter. FDA And QX good of fourth a since When began, Networks, elective our in results delivered Dave, slow. afternoon. In expectations. building. the XXXX issues the and an procedures. XXX(k) Thanks, since been months the result, significant and little impacting in were system off event, It’s and quarter milestones, which and ahead occurred is two started COVID-related
saw However, environment stronger surgical increase in as the improved, revenue. we and an a volumes
XXXX color While hospitals still improve, I’m to to one to conditions continued and a see takeaway and face the pleased leading commercialization these to bring insight top increased we we around is our factors some revolutionary expect and the throughout the plans. our we improvements comments the with staffing report of should to firmly in Today, and our resources This on will adoption healthcare unlock a company, to the us technologies into our the did. I to to market XXXX will why more shareholder my and value. substantially and beginning in different provide be of and related issues, and Networks line Inteneural into drive you raise year. market our ahead we the we’ve of believe have opportunity Holo This key time at Most pursued the market strategy opportunity The Surgalign revenue Surgical needed envisioned, to provide more focus acquisition strategy what I’ll market. guidance. accomplished earnest beyond. equity what investment,
distribution continue have innovate, as to and We our well product capture market to grow we as share. leverage expand opportunities portfolio revenue as
already or and is table. for value medical so Artificial device While many the creation well greatest in the market in through we to expected the market, continue recognized AI to spine the ways. conditions revolutionize platform field anticipate and is AI brings HOLO the Inteneural the opportunity especially intelligence Networks complementary if improve, to technology growth
for intend cost and these company AI patients. patient. healthcare for user in is I the room. is the AI and specific system currently each to surgery to a platform automatic combining vision AI IT build footprint is to HOLO improve much in to AI is upon is And facilitate platform, hospital’s The become which our savings the segmentation it our surgeons, AR. by of outside guidance more to into surgical spine. Portal can suggests can to anatomy application HOLO to AI that hospitals greater and surgical leverage HOLO predictive we of outcomes under grand, the applications system the for deliver as and plan our outcomes operating providers, the related the the Our provides this integrated first environment We development clinical to a world value believe first deliver expand When cleared
surgeons, bullish healthcare that are to payers, patients digital and We drawn this will institutions, be solution.
from that within that and We knew, we have AI was data, AI medical initial believe and we This core product post-op. the still can care. we network. drive But anatomy, to and focus for diagnostics, our behind and know more disciplines to AI other numerous is surgery, have the vision with portfolio, algorithms, foundation, force We limitless. also distribution applied our insights improvements through beyond pre-op, the which spine lives in are in transactions. spinal relates medical Thus spine be various it’s applications our believe healthcare. market, Thus, patient a into it driving premise improving our broadly logical strong
just improve just better surgery broader to are OR the tools and spine. help our continuum the perform touching spine the but to providing to procedures start every in is care, part We of going related outcomes by the vision not surgeons patient to not surgical of
and which It’s that reduces surgeons visualization technologies. through used the with system, HOLO procedures, AI in our AR spinal leveraging So augmented guidance begins journey competitors. platform intraoperatively Portal first reality differentiates AI is to us the surgical load improves operating The cognitive the the guide room. however, surgeon’s from our and
and with helps the can surgeon outcomes or the surgical Our a in and adjust operating plan room. efficiencies AI segments user spinal the suggests confidence, anatomy automatically follow and improve
we post-op AI HOLO to outside operating diagnostic analysis room technology to apply autonomous of the results. perform Second, imaging of both plan and
condition, applied the collected better treatment CT understand human disease, to single at on set and and relevant with et is scans, and of Here, other severity image measure. to a algorithm. comorbidities, the a surgeon x-rays, a They decisions like eyes developing the Currently gray patient’s to in shade of makes data medical every MRIs, support team where looks cetera, data can. on computer cannot an analyze and pixel of
common identifies differentiate we the Our relevant can the that take clinically to are structure, soft nervous our and medical of designed tissue, in level. quantify algorithms algorithm. specific After anatomical are measurements very software and down developing the structures treatment to another one vascular these forms imaging volumetric bone, in from values pixel
the applications HOLO spine AI platform degeneration. clinical first be and will disc in stenosis Our for
As algorithms an spinal the example, of of are and analysis the volumetric eliminating spinal greater in stenosis, efficiency. the error pathologies, provide a precise, with evaluation the human potential quantifiable of presenting with autonomously patient potential severity for
outcomes. make We provide authorization decision patient and to payer believe improve physicians clinical that and this with prior also efficient more making workflows will can data drive more better
of to We will those capabilities spine. in build address other a variety pathologies on
into of addition to we intracranial Networks the With extend Inteneural indications. will platform, the whole
aneurysms time. the Our surveillance first application and of be identify monitor to over will autonomously
diseases, We stroke, in dementia, Alzheimer’s, and autism, highly additional autonomously such brain. fall multiple as on the tumors, with then clinical to other pathologies applications identify will sclerosis, complex and monitor
has and AI HOLO musculoskeletal neural the a other variety lung, are of that to areas Third, cetera. organs to include networks many we et liver, platform and applying vessels kidneys,
be Portal and medical HOLO to treatment in expand the platform medical as our a strategy therapies. specialties business, surgical market treatment smaller role, care, many likely and diagnostic other course of the undergo substantial of the AI Our HOLO opportunity you pie many the most believe patients who to consider although types will of piece never appropriate is other will surgery. AI play We developing when seek
to platform data on the capabilities will add the healthcare enable component. and central as with body us for other Our the continuum of capabilities across broaden parts of approach our entire quickly
our but can so So the participate is focused within intracranial spine platform right now, we thereafter, that the are broader shortly strategy significantly we to on our medicine. expand and markets in
hospitals through many innovation XX% as of will agree are research and ways and published The reported as so certainly expand show and there our are than occur today grow final where outcomes beyond addressable operating As market enhancements surgery There as room here we’ve in an is envision what not question. there market an AI patient looking improvements our of reality to procedures many outcomes. $X and The a we resulted In significant to we we willing more we area that spine we And States, technology move market, But the performed about and points X.X hospitals X,XXX outcomes spoken is far data to million see this XXX,XXX rooms, market XXXX. big be different this what are billion approximately over surgical HOLO clinicians the navigation invest. estimated are our in market with the instrumented addressing the opportunity for today. intend the think robotics because digital and United based will platform. addressable is shows on market in many data. to it’s to by end non-successful annually of continues as that few there the future market
and biologics surgeries. and not in play and data applied represent intervention annually. is So and our markets, spine power opportunity we navigation Surgalign diagnostics, of areas medicine. And of the the AI piece, the with if imaging hardware in unique we other then robotics AI just is existing spine with for and and layer dollars our big does billions in continuums couple the addressable It to again, today market for full this networks of diagnostic
the be at applications broader opportunity that market our other will considering time. over built AI and Looking platform into
in market and billion for years. AI $XXX-plus for believe will this opportunity about better Surgalign talking a be And player XX We’re next you the leading space. healthcare
So our how system. do get we First, we Portal on focus adoption of early HOLO there?
a different commercialization. a models there use model, outright fee As models sales rental I’ve sell per mentioned sale, available for lease have will We system options. or the previously, be as capital
As as discretionary room the needs stages, to spend predict it’s split we’re in the what varies. and be hard decisions, budgeting initial will operating
we the previously, QX for I spine. XXX(k) Portal system received HOLO guidance surgical the in lumbar use in clearance of As mentioned the
platform led now the commercialization augmented we as the digital communities. big by than begin six was future. data years milestone of major pioneers culmination medical of health of the more first reality, our and AI, in The and mining This development
team. Surgalign site we We first our with to had have early our running the case HOLO we our another like week, milestone. reached our expectations, and using the commercial of thank first successful major now Last I’d congratulate Portal launch. and entire stages moved and up In into line performed system.
through data we more year, the more models that quicker assess adoption. accurately As the we’ll best feedback move the in have work to and and result
and and revenue we generated a plans a additional XXXX. year quarter to year sites total least to And $X.X As $X at million. early reminder, X per running up our with XX expected to have to launch is the is to million XX goal operational have unit be end commercial have from in broader by this approximately
of Over commercialization HOLO and our on the AI platform two next procedural expanding technologies relevant system, years, HOLO our Portal integrating will capabilities. be focus the
assets recurring our applications by have cost this clearances with networks acquisition new do team by and basis to are data technology. Surgical investment on solutions and focused The we HOLO pursuing greater all in continued we are with AI onto algorithms, machine We transactions and a on algorithms. bottom learning building new investments innovation new powered will line development dramatically through streams and and and internal FDA impact. bringing Holo expanded expanded and biggest layered and capabilities our aggregation, the indications revenue will lower on the market operate acquired create AI believe in We platform, as upgraded
enhance opportunity sales Without We have we our runway, throughout marketing we building top back have allowing scale invest. support ramping about our now networks To primary the That our as as on operational to achieve there, a our can reason enhance the have require scale R&D that The strategy. and necessary extend to to clear is To stage. scale, to platform we had year. will technology, the that lives. Portal we which is equity resources, capital our platform of team move we the capabilities needed and to get cases, it’s in beyond would’ve commercialize and did will is to raise invest HOLO resources the the us and opportunistically QX run new begun patient capital. improve efforts, to be
are early in lasers to full on We focused moving from scale R&D commercialization XXXX.
Surgalign. networks and We revolutionize to of power technologies at HOLO about healthcare the the internal are excited potential platform industry. have incredibly future The the
Surgalign We excited our and new also hired cadence portfolio introductions update proud spine market. we’ve is that, about the to I to ability execute talent and are full existing for critical potential. and adoption over year to spine the of realize support progress that Dave. to of am turn This in will the like I’d our confident the made product With our within and plan are the our call
